ANI Pharmaceuticals develops, manufactures and markets top quality prescription and over-the-counter pharmaceuticals, made in the U.S.A.
ETFs with exposure to ANI Pharmaceuticals, Inc. : November 16, 2017 Thu, 16 Nov 2017 16:09:47 +0000 Categories: ETFs Yahoo FinanceClick here to see latest analysis ETFs with exposure to ANI Pharmaceuticals, Inc. Here are 5 ETFs with the largest exposure to ANIP-US. Comparing the performance and risk of ANI Pharmaceuticals, Inc. with the ETFs that have exposure to it gives us some ETF choices that could give us similar returns with lower volatility. Ticker ... Read more
(Read more...)
ANI Pharmaceuticals, Inc. :ANIP-US: Earnings Analysis: Q3, 2017 By the Numbers : November 3, 2017 Fri, 03 Nov 2017 14:01:58 +0000 Categories: Yahoo FinanceGet free summary analysis ANI Pharmaceuticals, Inc. reports financial results for the quarter ended September 30, 2017. We analyze the earnings along side the following peers of ANI Pharmaceuticals, Inc. – Pfizer Inc. and Novartis AG Sponsored ADR (PFE-US and NVS-US) that have also reported for this period. Highlights Summary numbers: Revenues of USD 48.16 ... Read more
(Read more...)
ANI posts 3Q profit Thu, 02 Nov 2017 13:11:17 +0000 On a per-share basis, the Baudette, Minnesota-based company said it had net income of 40 cents. Earnings, adjusted for one-time gains and costs, were $1.11 per share. The drugmaker posted revenue of $48.2 ...
ETFs with exposure to ANI Pharmaceuticals, Inc. : October 16, 2017 Mon, 16 Oct 2017 13:48:04 +0000 Categories: ETFs Yahoo FinanceClick here to see latest analysis ETFs with exposure to ANI Pharmaceuticals, Inc. Here are 5 ETFs with the largest exposure to ANIP-US. Comparing the performance and risk of ANI Pharmaceuticals, Inc. with the ETFs that have exposure to it gives us some ETF choices that could give us similar returns with lower volatility. Ticker ... Read more
(Read more...)
ANI Pharmaceuticals Inc (ANIP): Can It Deliver A Superior ROE To The Industry? Mon, 02 Oct 2017 17:22:12 +0000 ANI Pharmaceuticals Inc’s (NASDAQ:ANIP) most recent return on equity was a substandard 3.11% relative to its industry performance of 18.27% over the past year. An investor may attribute an inferiorRead More...
ETFs with exposure to ANI Pharmaceuticals, Inc. : September 19, 2017 Tue, 19 Sep 2017 20:58:09 +0000 Categories: ETFs Yahoo FinanceClick here to see latest analysis ETFs with exposure to ANI Pharmaceuticals, Inc. Here are 5 ETFs with the largest exposure to ANIP-US. Comparing the performance and risk of ANI Pharmaceuticals, Inc. with the ETFs that have exposure to it gives us some ETF choices that could give us similar returns with lower volatility. Ticker ... Read more
(Read more...)
ANI Pharmaceuticals, Inc. :ANIP-US: Earnings Analysis: Q2, 2017 By the Numbers : September 5, 2017 Tue, 05 Sep 2017 16:41:15 +0000 Categories: Yahoo FinanceGet free summary analysis ANI Pharmaceuticals, Inc. reports financial results for the quarter ended June 30, 2017. We analyze the earnings along side the following peers of ANI Pharmaceuticals, Inc. – VIVUS, Inc., Jazz Pharmaceuticals Plc, Pfizer Inc., Infinity Pharmaceuticals, Inc., Novartis AG Sponsored ADR, Mylan N.V., Lannett Company, Inc., Teva Pharmaceutical Industries Limited Sponsored ... Read more
(Read more...)
*Winners defined as our Top Picks that increased 20% or more within a 6-month period.
Red Letters imply that that particular criteria did not meet minimum requirements, e.g., a low GSA Rank would show it in red.
___ Red Line On Graph Shows a Trailing Stop Loss Based on Support and Resistance Levels. See how it works.
___ Blue Line On Graph Shows the 10-Week Moving Average.
___ Magenta Line On Graph Shows the 40-Week Moving Average.
Disclaimer The stock selections in our stock investing and stock trading database are not stock recommendations, but simply represent applications of a stock investing process. All materials, including our Top Stock Picks, are provided for information purposes only and should not be used or construed as an offer to sell, a solicitation of an offer to buy, or a recommendation for any security. Growth Stock Analytics, LLC is not responsible for gains/losses that may result in investing or trading in these securities. All information is believed to be obtained from reliable sources, but there is no guarantee that the information supplied is accurate, complete or timely. There is no guarantee or warranty with regard to the results obtained from its use. There is no guarantee of suitability or potential value of any particular investment or information source. You acknowledge that your requests for this information are unsolicited and shall neither constitute nor be considered investment advice. Past investing performance is not an indication of future performance results. Investing and trading in stocks is risky. Investors are encouraged to consult a registered stock broker or investment adviser before making any investing decisions. The interpretations and opinions expressed herein are solely those of Growth Stock Analytics, LLC, and not of any other individual or organization.